These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21123189)

  • 1. A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains.
    Pan K; Subieta KC; Deem MW
    Protein Eng Des Sel; 2011 Mar; 24(3):291-9. PubMed ID: 21123189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain.
    Farnsworth A; Cyr TD; Li C; Wang J; Li X
    Vaccine; 2011 Feb; 29(8):1529-33. PubMed ID: 21211583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing sequence-based antigenic distance calculation into immunological shape space model.
    Anderson CS; Sangster MY; Yang H; Mariani TJ; Chaudhury S; Topham DJ
    BMC Bioinformatics; 2020 Jun; 21(1):256. PubMed ID: 32560624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.
    Anderson CS; McCall PR; Stern HA; Yang H; Topham DJ
    BMC Bioinformatics; 2018 Feb; 19(1):51. PubMed ID: 29433425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.
    Strengell M; Ikonen N; Ziegler T; Julkunen I
    PLoS One; 2011; 6(10):e25848. PubMed ID: 22022458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
    Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ
    PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene.
    Opanda S; Bulimo W; Gachara G; Ekuttan C; Amukoye E
    PLoS One; 2020; 15(2):e0228029. PubMed ID: 32045419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of antigenically advanced variants of seasonal influenza viruses.
    Li C; Hatta M; Burke DF; Ping J; Zhang Y; Ozawa M; Taft AS; Das SC; Hanson AP; Song J; Imai M; Wilker PR; Watanabe T; Watanabe S; Ito M; Iwatsuki-Horimoto K; Russell CA; James SL; Skepner E; Maher EA; Neumann G; Klimov AI; Kelso A; McCauley J; Wang D; Shu Y; Odagiri T; Tashiro M; Xu X; Wentworth DE; Katz JM; Cox NJ; Smith DJ; Kawaoka Y
    Nat Microbiol; 2016 May; 1(6):16058. PubMed ID: 27572841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.
    Durviaux S; Treanor J; Beran J; Duval X; Esen M; Feldman G; Frey SE; Launay O; Leroux-Roels G; McElhaney JE; Nowakowski A; Ruiz-Palacios GM; van Essen GA; Oostvogels L; Devaster JM; Walravens K
    Clin Vaccine Immunol; 2014 Mar; 21(3):271-9. PubMed ID: 24371255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention: Vaccine for all seasons.
    Schlütter J
    Nature; 2011 Nov; 480(7376):S6-8. PubMed ID: 22158298
    [No Abstract]   [Full Text] [Related]  

  • 13. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.
    Igarashi M; Ito K; Yoshida R; Tomabechi D; Kida H; Takada A
    PLoS One; 2010 Jan; 5(1):e8553. PubMed ID: 20049332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.
    Allen JD; Ross TM
    Hum Vaccin Immunother; 2018; 14(8):1840-1847. PubMed ID: 29641358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.
    Lee AJ; Das SR; Wang W; Fitzgerald T; Pickett BE; Aevermann BD; Topham DJ; Falsey AR; Scheuermann RH
    J Virol; 2015 May; 89(10):5427-40. PubMed ID: 25741011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and genetic variation in the hemagglutinins of H1N1 and H3N2 human influenza a viruses in the Shanghai area from 2005 to 2008.
    Ren XW; Ju LW; Yang JX; Lv XH; Jiang LF; Zhao NQ; Jiang QW
    J Med Virol; 2011 Jul; 83(7):1113-20. PubMed ID: 21520138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.